[ Price : $8.95]
A detailed ProPublica investigative report says FDA failed to inspect a Glenmark Pharmaceuticals facility in India that had multip...[ Price : $8.95]
After receiving a complete response letter, Lykos Therapeutics says it will pursue FDAs dispute resolution process to question the...[ Price : $8.95]
Reed Smith attorney James Beck says companies hit by FDA for off-label promotion may challenge the agencys reasoning under the new...[ Price : $8.95]
FDA extends by three months its review of a Syndax Pharmaceuticals NDA for revumenib and its use in treating adult and pediatric p...[ Price : $8.95]
A detailed FDLI analysis looks at how expected Supreme Court changes to the Chevron federal agency deference principle will likely...[ Price : $8.95]
FDA denies most elements in four Consumers for Dental Choice petitions seeking additional agency actions to stop or reduce amalgam...[ Price : $8.95]
A recent inspection at Dr. Reddys Laboratories active pharmaceutical ingredient manufacturing plant in Middleburg, NY cites three ...[ Price : $8.95]
FDA says it now recommends that people in seven high-risk categories refrain from exposure to dental mercury amalgam when possible...